CTi Biopharma Corp (CTIC.OQ)

CTIC.OQ on NASDAQ Stock Exchange Capital Market

2.44USD
19 Dec 2014
Price Change (% chg)

$0.01 (+0.41%)
Prev Close
$2.43
Open
$2.36
Day's High
$2.51
Day's Low
$2.36
Volume
1,620,901
Avg. Vol
299,769
52-wk High
$4.25
52-wk Low
$1.71

CTIC.OQ

Chart for CTIC.OQ

About

CTI BioPharma Corp. (CTI), formerly Cell Therapeutics, Inc., is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic ways to treats cancer. The Company is concentrating its efforts on treatments that target blood-related cancers where there is an unmet medical need. The Company... (more)

Overall

Beta: 1.06
Market Cap (Mil.): $388.18
Shares Outstanding (Mil.): 159.09
Dividend: --
Yield (%): --

Financials

  CTIC.OQ Industry Sector
P/E (TTM): -- 179.07 38.47
EPS (TTM): -0.28 -- --
ROI: -118.26 -0.72 18.25
ROE: -386.03 -1.88 19.13
Search Stocks

BUZZ-U.S. Stocks on the Move-Haliburton, EMC Corp, CTI Biopharma

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S. stocks dipped at the open on Monday as developments in Ukraine and the Gaza Strip look to dominate trading amid a thin economic calendar. The Dow Jones industrial average was down 0.39 percent at 17,032.78, t

21 Jul 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks